Literature DB >> 21590396

Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.

Edwige Dormond1, Amine A Kamen.   

Abstract

Adenoviral vector (AdV) of the third generation also known as helper-dependent adenoviral vector (HDV) is an attractive delivery system for gene therapy applications. However, obtaining high quality-grade HDV in sufficient amount remains a challenge that hampers the extensive use of this vector in preclinical and clinical studies. Here we review recent progress in the large-scale manufacturing of HDV. The production of HDV is now amenable to large-scale volume with reduced process duration under optimized rescue and co-infection conditions. Also, efficient downstream processing of HDV with acceptable recovery of HDV and minimal contamination by the helper virus is described.

Mesh:

Year:  2011        PMID: 21590396     DOI: 10.1007/978-1-61779-095-9_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Gene therapy for skin diseases.

Authors:  Emily Gorell; Ngon Nguyen; Alfred Lane; Zurab Siprashvili
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

2.  Adenovirus-mediated dual gene expression of human interleukin-10 and hepatic growth factor exerts protective effect against CCl4-induced hepatocyte injury in rats.

Authors:  Hong Qiu; Yan Yan; Jicheng Xing; Yuerong Zhu; Lin Fang; Xiangrong Cao; Changqing Su
Journal:  Dig Dis Sci       Date:  2012-03-08       Impact factor: 3.199

Review 3.  Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.

Authors:  C W Peterson; P Younan; K R Jerome; H-P Kiem
Journal:  Gene Ther       Date:  2013-01-31       Impact factor: 5.250

4.  iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapy.

Authors:  Dominik Brücher; Nicole Kirchhammer; Sheena N Smith; Jatina Schumacher; Nina Schumacher; Jonas Kolibius; Patrick C Freitag; Markus Schmid; Fabian Weiss; Corina Keller; Melanie Grove; Urs F Greber; Alfred Zippelius; Andreas Plückthun
Journal:  Mol Ther Methods Clin Dev       Date:  2021-01-20       Impact factor: 6.698

5.  Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks.

Authors:  Lukasz Kuryk; Anne-Sophie W Møller; Antti Vuolanto; Sari Pesonen; Mariangela Garofalo; Vincenzo Cerullo; Magnus Jaderberg
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.